Eksaminator: Ph.d.-forsvar Odd Lilleng Gammelgaard: Development and evaluation of novel antibody-based targeting strategies of CD73 for cancer treatment

Barington, T. (Eksaminator)

Aktivitet: Censoraktivitet og eksamineringIntern eksaminator

Periode9. dec. 2019
EksaminandOdd Lilleng Gammelgaard